SYNVISC ONE
Live / Registered — Registered and renewed (as of 25 Mar 2019)
What this means for you
Registered since 21 Oct 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Oct 2018).
Record
- Serial number
- 77228235
- Registration number
- 3521857
- Mark type
- Design + words
- Filed
- 12 Jul 2007
- Published for opposition
- 25 Dec 2007
- Registered
- 21 Oct 2008
- Next maintenance due
- 21 Oct 2018
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, prepackaged injectable biochemical solutions, namely, sodium hylan solutions
- Class 010 — Medical apparatus: Medical apparatus, namely, a self-contained syringe for dispensing prepackaged injectable sodium hylan solutions for use in surgery
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Apr 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Apr 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 Mar 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 25 Mar 2019 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 25 Mar 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 25 Mar 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Feb 2019 — TEAS SECTION 8 & 9 RECEIVED
- 21 Oct 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Nov 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Nov 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Nov 2013 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED